•   
  •   
  •   

Health & Fit U.S. FDA says carcinogen not found in alternatives of Zantac and its generics

17:30  24 october  2019
17:30  24 october  2019 Source:   reuters.com

These Breast Implants Have Been Recalled Because of Their Link to a Rare Cancer

These Breast Implants Have Been Recalled Because of Their Link to a Rare Cancer And what to do if you have breast implants. What exactly was recalled? This recall applies to BIOCELL textured breast implants and tissue expanders (devices used to stretch a person’s skin before breast augmentation or reconstruction after a mastectomy) from Allergan. Before we get into the details of what BIOCELL means, the first thing to know if you have breast implants and are worried: Textured implants are uncommon in the United States, making up only 10 percent of breast implants sold in this country, according to the FDA.

Oct 23 (Reuters) - The U.S. Food and Drug Administration said on Wednesday that alternatives to popular heartburn drug Zantac and its generic versions, known chemically as ranitidine, have not been found to contain the probable cancer-causing impurity that ranitidine has been linked to. (http://bit.ly/2oYJ1Vz)

  U.S. FDA says carcinogen not found in alternatives of Zantac and its generics © golibtolibov/Getty Images

U.S. retailers Walmart Inc, CVS Health Corp Walgreens Boots Alliance Inc and Rite Aid Corp have all removed Zantac off their shelves after some drugs containing its key ingredient ranitidine were found to have traces of the impurity, N-nitrosodimethylamine (NDMA).

Related video: Zantac and its generic version found with chemical that could lead to cancer (CBS News)

18 Menswear Sales to Hop On Pronto (Including the Perfect Fall Pants)

  18 Menswear Sales to Hop On Pronto (Including the Perfect Fall Pants) Save big this weekend.

Early tests of alternatives to over-the-counter ranitidine, such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec show no NDMA, the agency said.

The FDA said earlier this month it found unacceptable levels of NDMA in drugs containing ranitidine. The regulator asked ranitidine makers to conduct their own testing to assess levels of the impurity and to send samples of their products for testing by the agency.

French drugmaker Sanofi SA last week said it would recall Zantac in the United States and Canada.

NDMA had previously been found in some blood pressure medicines from a class of drugs known as angiotensin II receptor blockers, or ARBs. The potentially cancer-causing impurities are believed to have been introduced by recent changes in the manufacturing process for the drugs. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber)

Why Did the Pentagon Push the FDA to Approve a Powerful New Opioid? .
The Defense Department pushed for the drug’s expedited approval and confidently endorses its benefits, but may know very little about it.In November 2018, the Food and Drug Administration approved America’s newest opioid, a formulation of sufentanil called Dsuvia. Sufentanil is the strongest prescription painkiller available—five to 10 times more potent than its parent drug fentanyl, which is in turn 30-50 times more potent than heroin. The outcry over Dsuvia—its potency, its potential for abuse—was immediate.

Topical videos:

usr: 3
This is interesting!